Canine distemper virus (CDV) has been implicated in some recent deaths of lions, which showed clinical signs of distemper, in the the Serengeti plain. Similar clinical findings have since been reported in lions of the Masai Mara. Fifty-five per cent of serum samples obtained from wild lions of the Masai Mara have been found to contain neutralising antibody to CDV, indicating that they had been exposed to the virus. Adult orphan lions kept in captivity, were vaccinated with the live attenuated Onderstepoort strain of CDV. The results indicated that the vaccine is both safe and immunogenic, and may be potentially useful for the prophylactic vaccination of lions at high risk.
CANINE distemper virus (CDV) is a member of the Morbilliviridae and a potentially fatal disease of Canidae, although it has a wider host range under natural and experimental conditions (Appel and Gillespie 1972) . In 1994, CDV infections were responsible for the deaths of a significant proportion of the wild lion (Panthero leo) population in the Serengeti plain in northern Tanzania (Spencer 1995) . Seventy-one of 83 (85 per cent) of the blood samples taken from the lions were found to be CDV antibody-positive, and viral antigen was obtained from two lions (Roelke-Parker and others 1996) . Barrett and others (1993) have found that the phosphoprotein (P) gene sequence varies between moribilliviruses and they have used this property to distinguish differences or show similarities between isolates. The differences in the (P) gene sequence are also useful for determining phylogenetic relationships. The (P) gene fragment of the morbillivirus isolated from the diseased lions was amplified by polymerase chain reaction (PCR) and analysed and it was concluded that the isolate was more similar to CDV than to the other morbilliviruses (Harder and others 1995). One hypothesis to account for CDV infection in lions is that the virus crossed the species barrier from the domestic dog population, of which approximately 30,000 are reported to live in close proximity to the Serengeti, and in which CDV has previously been recorded (Roelke-Parker and others 1996) . The role of hyaenas, jackals, and other susceptible species in the spread of the disease is however still uncertain, although CDV was isolated from a bat-eared fox (Otocycon megalotis) and a spotted hyaena (Crocuta crocuta) R. Kock There are conflicting theories about how to prevent or reduce disease conditions in wildlife. Harder and others (1995) have suggested that the best strategy would be to vaccinate the surrounding domestic dog population, the suspected reservoir of the infection, with CDV vaccines which have been shown to be safe. Their main concern was that some attenuated vaccines might induce CDV disease in susceptible wild carnivores, a concern also voiced by Morrell (1994) . Conversely, Appel and others (1994) , reporting on deaths due to CDV in exotic Felidae in North American zoos and wildlife parks, proposed that attenuated chick embryo-adapted vaccines could be used once their safety had been demonstrated in wildlife.
The Masai Mara in Kenya and the Serengeti plain in Tanzania form one continuous ecosystem divided only by political boundaries which are recognised by neither animals nor pathogens. There is a constant exchange of wildlife between the two areas. This paper presents the results of a small serological survey of CDV antibodies in serum samples from lions of the Masai Mara and describes the responses of lions inoculated with a live attenuated CDV vaccine.
Materials and methods

Serum samples
Between October 1994 and February 1995, 55 To investigate the variation with age in the proportion of seropositive lions it was necessary to control for any sex difference. A multivariate analysis of variance was therefore carried out by using the statistical software package GLIM (Crawley 1993) . The appropriate link function (logistic) and error structure (binomial) for the analysis of proportional data were specified. Any non-significant variables (P>0-05) were removed from the statistical model. Consecutive yearly age classes were then grouped together, provided there was no significant impact on the fit of the model, to produce a minimal adequate model. The absence of bias in the seroprevalence of the lions whose ages had been estimated compared with those for which no estimates of age were available was confirmed by using a x2 test. Unfortunately, unlike the Serengeti, no previous serological data are available from the Masai Mara from which the CDV status of its lion population before August 1994 can be assessed. The results suggest a 'step-like' age seroprevalence, with lions alive in 1990 having a significantly higher seroprevalence than lions born after 1-990. As the antibody response to CDV lasts many years, the pattern of seroprevalence with age may be due either to previous exposure to infection, or to the variation in infection with age during a recent outbreak. More specifically, the age seroprevalence may be explained by the differential transmission of CDV with age during the 1994 epidemic, or by the differential age mortality rates due to CDV infection in 1994, or by the age-constant CDV infection during two epidemics, one starting in 1990 and the other starting in 1994.
The results from the Serengeti, however, are not consistent with the first two explanations. In the Serengeti lion population, CDV infection and increased mortality were reported among all ageclasses equally (Roelke-Parker and others 1996). In the Serengeti, there have been long-term research studies of the lion population, but there have been no comparable studies with the Masai Mara. As a result, it was not possible to estimate increased disease-related mortality rates. However, there is no reason to believe that the progression of disease in the Masai Mara lions would have been different from that observed in the Serengeti.
The possibility of previous exposure to distemper infection is, however, consistent with the last-reported CDV epidwaeiic in the area which started in late 1990 in the domestic dog population surrounding the Masai Mara (Alexander and Appel 1994 lier serological survey by Alexander and Appel (1994) suggested that during this 1990 epidemic, CDV was transmitted from the domestic dog population to other wild carnivores in the region, including wild dogs (Lycaon pictus) and hyaenas. In Tanzania, a retrospective analysis of serum samples collected in the 1980s, indicates that lions in the Serengeti ecosystem had previously been exposed to CDV without an increase in disease-related mortality (Roelke-Parker and others 1996) . It therefore seems plausible that during the 1990 CDV epidemic in the Masai Mara region, the lion population may have been exposed to CDV either directly from domestic dogs or from other wild carnivores, such as hyaenas. Assuming age-constant infection and disease-related mortality rates, the observed cross-sectional seroprevalence data may therefore be explained by a CDV outbreak in 1990, followed by a more recent epidemic starting in 1994.
The significant male bias in seroprevalence in the Masai Mara is different from the Serengeti, where there were no differences in the proportions of the sexes which were seropositive. There is no clear explanation for this sex difference in seroprevalence.
The results of the serological survey and the findings from Tanzania, support the theory that the recent CDV epidemic spread through the lion populations of the Serengeti-Masai Mara ecosystems. The higher seroprevalence in animals alive at the time of the last known CDV epidemic in the Masai Mara region is consistent with the previous exposure of Masai Mara lions to CDV.
Vaccination
The experimental inoculation of domestic cats with canine distemper virus has produced no evidence of typical clinical signs of CDV, the only evidence of infection being found by the histopathological examination of infected tissue (Appel and others 1974) . The Onderstepoort strain of CDV (Nobivac D; Intervet) passaged in tissue culture cells, has been shown to produce good antibody responses in fox, mink and ferret without spreading or being disseminated or causing adverse clinical reactions (W. S. K.
Chalmers, unpublished observations). The results of this small study have shown that vaccinal virus will replicate and stimulate an antibody response in the majority of vaccinated cats. However, the vaccinal strain was more efficacious in wild lions in that the take rate was 100 per cent, it did not spread to in-contact lions, it produced much higher protective neutralising antibody titres, and no adverse clinical signs were recorded.
It has been proposed that inactivated vaccines should be used to prevent infection because it is believed that attenuated vaccines may produce distemper in susceptible carnivores. However, the neutralising antibodies produced by inactivated vaccines are often poor and short-lived compared with those stimulated by live attenuated vaccines. It is not suggested that the lion population in the Masai Mara-Serengeti should be vaccinated, first because it would be impractical, and secondly because the population is large enough to recover without intervention. Ring vaccination of the domestic dogs which are the main reservoir of infection may be feasible, because these dogs can be collected in the surrounding Masai villages for sampling, vaccination and monitoring over a defined period. Emmons and others 1983, Burgess and Mattison 1987) . Bacterial infections of the central nervous system (CNS) of adult horses have rarely been reported and are generally fatal (Mayhew and Mackay 1982, Foreman and Santschi 1989) . They can occur in all ages and breeds but are more prevalent in neonates when they are most often secondary to septicaemia (Mackay and Mayhew 1991) . Beta-haemolytic streptococci are probably the most commonly isolated bacteria, and meningoencephalitis can be a complication of strangles or respiratory disease (Ford and Lokai 1980 , Smith and others 1987 , Sweeney and others 1987 , Johnston 1994 .
The clinical signs are diverse because the nervous system, like most other body systems, responds to insult in limited ways (Smith and others 1987) . Diagnosis can therefore be difficult but if treatment is delayed until overt clinical signs are evident, the prognosis is poor (Foreman and Santschi 1989).
